FCF Grants Awarded to University of Washington
Total grants: 9
- Biochemical and functional characterization of DNAJ-PKAc modulators — Principal investigator(s): John Scott — 2025
- The Metabolic Implications and Targetability of Mitochondrial Calcium Signaling in FLC — Principal investigator(s): Yasemin Sancak — 2025
- Molecular therapies for fibrolamellar carcinoma (FLC) – continuation — Principal investigator(s): John Scott — 2023
- Therapeutic modulation of tumor-infiltrating T cell function in fibrolamellar carcinoma — Principal investigator(s): Venu Pillarisetty, Kevin Barry — 2023
- Molecular therapies for fibrolamellar carcinoma (FLC) – extension — Principal investigator(s): John Scott — 2021
- Modulating stromal-immune cell interactions to activate anti-tumor immunity to fibrolamellar carcinoma — Principal investigator(s): Venu Pillarisetty — 2020
- Molecular therapies for fibrolamellar carcinoma (FLC) — Principal investigator(s): John Scott — 2019
- Therapeutic innovations in fibrolamellar cancer — Principal investigator(s): Raymond Yeung — 2017
- T cell immunotherapy in fibrolamellar cancer — Principal investigator(s): Kevin M. Sullivan — 2016
This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded to University of Washington.